Role of map and aip in prediction of cvd risk in type 2 diabetic patients with and without metabolic syndrome.

Authors:Priya. K.Dhas, G.Ramani, G.Kavitha , Rita Mary Aruna
Int J Biol Med Res. 2013; 4(1): 2952-2957  |  PDF File

Abstract

Abstract: Metabolic stress is associated with increased risk of cardiovascular morbidity and mortality. Aim: To analyze the role of MAP and AIP in predicting CVD risk in type 2 diabetic patients with metabolic syndrome and inclusion of these parameters in defining MS. Materials and Methods: 120, Type 2 diabetic patients aged between 40-60 yrs were included in this study. They are categorized as diabetic patients with metabolic syndrome (n=60) and diabetic patients without metabolic syndrome (n=60) by fulfilling at least 3 criteria of NCEP (ATP) III. Their anthropometric characteristics were measured and MAP was calculated. FBS, lipid profile were estimated and atherogenic index of plasma was calculated. Result: A significant increase was observed in waist circumference, BP, MAP, lipid profile and AIP of diabetic patients with metabolic syndrome when compared to diabetic patients without metabolic syndrome. Hence the study suggests that MAP and AIP may serve as a better indicator in assessing metabolic syndrome among type 2 diabetes mellitus.